Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PsyBio Therapeutics has initiated process development of its proprietary biosynthetic formulation of norbaeocystin in collaboration with the Advanced Biofuels and Bioproducts Process Development Unit.
read more
PSI CRO, a global full-service contract research organization, is opening a new office in Durham, North Carolina, in the region known as Research Triangle Park (RTP).
read more
Thursday, January 15, 2026
PSI CRO announced further expansion in Japan, with the opening of the second office located on Level 18 of the Hilton Plaza West Office Tower in Umeda, Kita-ku, Osaka.
read more
Friday, September 22, 2017
PSI CRO has announced opening offices in Taiwan, listed as Taiwan PSI Health Development at TAIPEI 101 TOWER, Taipei, Taiwan.
read more
Wednesday, January 07, 2026
PSI CRO, a Swiss-based contract research organization, has expanded its Toronto operations with the opening of a new office location in Ontario. The expansion builds on PSI’s long-standing presence in the Canadian clinical trial market, where the ...
read more
Wednesday, September 27, 2017
goBalto announced that PSI CRO has chosen goBalto's complete suite of SSU applications for all studies on a worldwide basis to further bolster their clinical study startup process.
read more
Monday, November 29, 2021
Provepharm Life Solutions, a French private pharmaceutical company that finds new applications for well-known molecules, today announces that it has been granted FDA (Food and Drug Administration) authorization to produce its own Active ...
read more
Wednesday, December 16, 2020
Provepharm Life Solutions has announced its acquisition of Apollo Pharmaceuticals USA, a company that specializes in the commercialization of sterile injectable products for hospital use.
read more
ProTrials Research, Inc., has announced the awarding and initiation of an agreement with Calithera Biosciences Inc., a clinical stage biotechnology company focused on the discovery and development of novel small molecule drugs directed against tumor ...
read more
Wednesday, February 15, 2017
ProTrials Research has announced the expansion of their suite of services to include data management. In response to the evolving needs of their clients, ProTrials has broadened their offering, adding both data management services and a variety of ...
read more
ProThera Biologics and Takeda have entered into a global licensing agreement to develop a novel plasma-derived IAIP therapy for the treatment of acute inflammatory conditions.
read more
Monday, December 17, 2018
Proteostasis announced a worldwide, exclusive license agreement with Genentech for rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network.
read more
ProteoNic and NecstGen announced a partnership for the development of improved viral vector manufacturing for gene therapy applications.
read more
Proteon Therapeutics announced a long-term contract extension with Lonza Pharma & Biotech for the commercial supply of investigational vonapanitase’s active pharmaceutical ingredient.
read more
ProteoGenix , Aseem Healthcare, and Trident Biopharm Solutions announced the development of a new antibody cocktail effective against major variants of SARS-CoV-2. The cocktail of four fully human neutralizing antibodies (AH-5-COV) was generated by ...
read more